Prot #20101129/GOG-3001: A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of AMG 386 With Paclitaxel and Carboplatin as First-line Treatment of Subjects With FIGO Stage III-IV Epithelial Ovarian, Primary Peritoneal, or Fallopian T

    Project: Research project

    Project Details

    StatusFinished
    Effective start/end date12/30/1312/30/16

    Funding

    • Gynecologic Oncology Group (Prot #20101129/GOG-3001)
    • Amgen, Inc. (Prot #20101129/GOG-3001)